GMED vs USB · P/E 42, rev $1.55B vs P/E 12, rev $7.71B
Globus Medical (GMED) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Globus Medical (GMED) is a medical devices company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported GMED revenue for 2026-06-30 was $1.55B. Net income was $275.9M. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
Latest reported USB revenue for 2026-06-30 was $7.71B. Net income was $2.18B. Revenue was up 5.8% from 2026-03-31 to 2026-06-30. USB currently screens at market cap $74.68B and trailing P/E 11.9.
GMED currently screens at market cap $7.66B and trailing P/E 42.1. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the GMED and USB stock pages for the full models.
Not investment advice.